About US
Contact us
-
Roche's Perjeta helps breast cancer patients live a record-setting 15.7 months longerThese days, even expensive cancer treatments don't necessarily deliver show-stopping study results when it comes to actually extending patients' lives. Roche's ($RHHBY)Perjetais now a major departure2014/9/30
-
ESMO: The latest skinny on drugs from Pfizer, Novartis, GSK, Merck, BMSThe European Society for Medical Oncology meeting may not be as enormous as its U.S. counterpart, but plenty of news is flowing. And some of the new data presented in Madrid over the weekend is pretty2014/9/30
-
Pfizer preps its case for FDA pulling Chantix's black-box warningThe FDA polished up the official label on Pfizer's stop-smoking drugChantixearlier this week. It was a victory for Pfizer ($PFE), the payoff from several studies testing the drug for psychiatric side2014/9/29
-
AstraZeneca unloads discontinued injectables to specialty generics maker IGITalk about selling off old products. AstraZeneca ($AZN) has unloaded 18 drugs it no longer sells to specialty generics maker IGI Laboratories. Apparently, IGI thinks it can profit from reintroducing m2014/9/29
-
China-Denmark Roundtable on Legislation and Supervision of Food Safety held in BeijingOn September 11, 2014, China-Denmark Roundtable on Legislation and Supervision of Food Safety was held in Beijing. China Food and Drug Administration (CFDA) Minister Zhang Yong and Prime Minister Hell2014/9/28
-
AAC issues safety message to consumers about cold and flu medicinesAs the countdown to cold and flu season begins, consumers are getting flu shots and increasing their purchases of cold and flu medicines. The Acetaminophen Awareness Coalition(AAC) is issuing a safety2014/9/26
-
3SBio signs exclusive license agreement with JenKem for PEG-irinotecan3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered in2014/9/26
-
IGI Laboratories acquires regulatory rights for 18 drug products from AstraZenecaIGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug2014/9/26
-
Micron Technologies to Exhibit at CPhIMicron Technologies is pleased to invite you to its booth 6P130 at the forthcoming CPhI Paris 2014. Micron Technologies provides contract particle size reduction and analytical services for the pharm2014/9/25
-
Meet Softigel by Procaps at CPhISoftigel by Procaps will be attending CPhI Worldwide in Paris from 7-9 October, where our team of experts will be available to discuss mutual opportunities. Softigel by Procaps offers product develop2014/9/25